← Eichor
Condition: Decompensated Liver Cirrhosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Decompensated Liver Cirrhosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hospital @ Home Model of Care for Cirrhosis
NA · 1 location(s) · Indiana University · NCT06396897Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
Phase 3 · 12 location(s) · Aleksander Krag · NCT05056220CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis
NA · 15 location(s) · University College, London · NCT06223893Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis
Phase 3 · 8 location(s) · Consorcio Centro de Investigación Biomédica en Red (CIBER) · NCT06533852Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
Phase 2 · 1 location(s) · Anahita Rabiee MD MHS · NCT06812390TIPS in Patients With Decompensated Liver Cirrhosis
Phase N/A · 1 location(s) · Hannover Medical School · NCT04801290The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrh
Phase N/A · 15 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07172035Study of microRNAs in a Decompensated Cirrhosis
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT03905746Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompens
NA · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06431919Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis
Phase 2 · 1 location(s) · CAMC Health System · NCT06764966Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standar
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT07002827Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis Infection
Phase N/A · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06039696RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Phase 1/Phase 2 · 14 location(s) · Resolution Therapeutics Limited · NCT06823713Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
Phase 2 · 1 location(s) · Giuseppe Cullaro, MD · NCT06937307LEOPARD Training and Validation Data Collection Study
Phase N/A · 22 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06675604Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
Phase N/A · 9 location(s) · European Foundation for Study of Chronic Liver Failure · NCT06855056Effect of Whey Protein Versus Egg Albumen Protein Challenge on Blood Ammonia Level in Patients of Decompensated Ethanol
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT07299110BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
Phase 4 · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06538077Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cir
NA · 1 location(s) · Grigore T. Popa University of Medicine and Pharmacy · NCT07437755CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis
Phase N/A · 1 location(s) · Beijing 302 Hospital · NCT04512833Hemostasis in Liver Cirrhosis and Hepatocellular Cancer
Phase N/A · 1 location(s) · Region Stockholm · NCT06212635Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)
Phase 2 · 7 location(s) · Beijing 302 Hospital · NCT05224960A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor
Phase 2 · 9 location(s) · European Foundation for Study of Chronic Liver Failure · NCT05895136hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
Phase 1 · 1 location(s) · Sclnow Biotechnology Co., Ltd. · NCT03826433Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
Phase 1 · 5 location(s) · Vir Biotechnology, Inc. · NCT05484206Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrh
Phase 1/Phase 2 · 1 location(s) · Beijing Tuohua Weiye Biotechnology Co., Ltd. · NCT07413549Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Pa
Phase 4 · 1 location(s) · Eva Bonfill · NCT05783661
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.